Skip to main content

Patients, physicians, and clinical trials: the other side of the coins.

Publication ,  Journal Article
Abramson, SB; Flexner, C; Snyderman, R; Dieterich, DT; Korn, D; Temple, R; Sherwood, L; Goldblatt, D
Published in: J Investig Med
September 1999

Duke Scholars

Published In

J Investig Med

ISSN

1081-5589

Publication Date

September 1999

Volume

47

Issue

8

Start / End Page

343 / 357

Location

England

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Research Support as Topic
  • Physician-Patient Relations
  • Patient Advocacy
  • Humans
  • General Clinical Medicine
  • Ethics, Medical
  • Drug Industry
  • Drug Approval
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Abramson, S. B., Flexner, C., Snyderman, R., Dieterich, D. T., Korn, D., Temple, R., … Goldblatt, D. (1999). Patients, physicians, and clinical trials: the other side of the coins. J Investig Med, 47(8), 343–357.
Abramson, S. B., C. Flexner, R. Snyderman, D. T. Dieterich, D. Korn, R. Temple, L. Sherwood, and D. Goldblatt. “Patients, physicians, and clinical trials: the other side of the coins.J Investig Med 47, no. 8 (September 1999): 343–57.
Abramson SB, Flexner C, Snyderman R, Dieterich DT, Korn D, Temple R, et al. Patients, physicians, and clinical trials: the other side of the coins. J Investig Med. 1999 Sep;47(8):343–57.
Abramson, S. B., et al. “Patients, physicians, and clinical trials: the other side of the coins.J Investig Med, vol. 47, no. 8, Sept. 1999, pp. 343–57.
Abramson SB, Flexner C, Snyderman R, Dieterich DT, Korn D, Temple R, Sherwood L, Goldblatt D. Patients, physicians, and clinical trials: the other side of the coins. J Investig Med. 1999 Sep;47(8):343–357.

Published In

J Investig Med

ISSN

1081-5589

Publication Date

September 1999

Volume

47

Issue

8

Start / End Page

343 / 357

Location

England

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Research Support as Topic
  • Physician-Patient Relations
  • Patient Advocacy
  • Humans
  • General Clinical Medicine
  • Ethics, Medical
  • Drug Industry
  • Drug Approval